American Society of Clinical Oncology (ASCO) shared a post on Facebook:
“Implementing advanced cancer screening doesn’t always require a highly expensive, high-tech laboratory.
Dr. Nora Pashayan’s research shows that “Precision Public Health” is highly adaptable – even for low- and middle-income countries (LMICs). By utilizing straightforward risk assessments like family history and lifestyle questionnaires, clinicians can prioritize screening for those at the highest risk, maximizing the impact of limited resources.
Learn how countries are already doing and how to bring these models to your community during the ASCOBT26 keynote.
Online registration is still open! Secure your spot at ASCOBT26 to access livestreams, downloadable slides, and on-demand session recordings from anywhere in the world.”
Other articles about ASCO on OncoDaily.